Hye-Ryun Kang Selected Research

Contrast Media

10/2022	Validation of Practical Pathway in Patients With Anaphylaxis to Low Osmolar Contrast Media: A Retrospective Cohort Study.
7/2022	Diagnosis and Prevention of Hypersensitivity Reactions to Iodinated Contrast Media.
1/2022	Allergic-like Hypersensitivity Reactions to Gadolinium-based Contrast Agents: An 8-year Cohort Study of 154 539 Patients.
1/2021	Finding the Optimal Alternative for Immediate Hypersensitivity to Low-Osmolar Iodinated Contrast.
1/2021	Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity.
1/2021	The Use of Contrast Agents in Interventional Pain Procedures: A Multispecialty and Multisociety Practice Advisory on Nephrogenic Systemic Fibrosis, Gadolinium Deposition in the Brain, Encephalopathy After Unintentional Intrathecal Gadolinium Injection, and Hypersensitivity Reactions.
10/2020	Diagnostic procedures & practices in drug allergy/hypersensitivity: a survey of 13 Asian countries.
1/2020	HLA-DRB1*15: 02 Is Associated With Iodinated Contrast Media-Related Anaphylaxis.
1/2020	Corticosteroid prophylaxis may be not required for patients with mild hypersensitivity reaction to low-osmolar contrast media.
1/2020	Drug hypersensitivity reactions in Asia: regional issues and challenges.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hye-Ryun Kang Research Topics

Disease

36	Hypersensitivity (Allergy) 07/2022 - 05/2011
26	Asthma (Bronchial Asthma) 01/2022 - 02/2004
12	Inflammation (Inflammations) 01/2022 - 02/2004
11	Cicatrix (Scar) 01/2022 - 05/2011
10	Anaphylaxis (Anaphylactic Shock) 10/2022 - 11/2011
9	Respiratory Hypersensitivity 11/2022 - 02/2004
8	Stevens-Johnson Syndrome (Lyell's Syndrome) 11/2019 - 06/2010
7	Drug Hypersensitivity (Drug Allergy) 07/2022 - 03/2014
6	Drug-Related Side Effects and Adverse Reactions 01/2022 - 11/2011
6	Fibrosis (Cirrhosis) 01/2022 - 07/2006
5	Eosinophilia 08/2020 - 02/2004
5	Chronic Renal Insufficiency 11/2019 - 01/2009
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2021 - 03/2007
4	Drug Hypersensitivity Syndrome 01/2021 - 11/2011
4	Neoplasms (Cancer) 01/2020 - 01/2014
3	Immediate Hypersensitivity 02/2022 - 08/2012
3	Pneumonia (Pneumonitis) 12/2021 - 03/2008
3	Allergic Rhinitis 05/2020 - 04/2011
3	Rhinitis 05/2020 - 02/2005
2	Hereditary Angioedemas 03/2022 - 01/2022
2	Exanthema (Rash) 01/2021 - 01/2020
2	Tuberculosis (Tuberculoses) 01/2021 - 02/2010
2	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2020 - 10/2019
2	Genetic Predisposition to Disease (Genetic Predisposition) 10/2019 - 05/2011
2	Chronic Urticaria 07/2017 - 03/2014
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2016 - 01/2014
2	Drug Eruptions (Drug Eruption) 09/2014 - 09/2012
2	Hyperuricemia 01/2014 - 11/2011
1	Hyperplasia 01/2022
1	Food Hypersensitivity (Food Allergy) 09/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Pain (Aches) 01/2021
1	Nephrogenic Fibrosing Dermopathy 01/2021
1	Epilepsy (Aura) 01/2021
1	Renal Insufficiency (Renal Failure) 01/2021

Drug/Important Bio-Agent (IBA)

25	Contrast MediaIBA 10/2022 - 11/2011
16	Pharmaceutical PreparationsIBA 01/2022 - 02/2010
12	HLA-B Antigens (HLA-B)IBA 01/2022 - 06/2010
12	Allopurinol (Remid)FDA LinkGeneric 01/2022 - 05/2011
10	Immunoglobulin E (IgE)IBA 07/2022 - 02/2004
9	OvalbuminIBA 11/2022 - 02/2004
7	AllergensIBA 01/2021 - 02/2004
6	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 05/2011
5	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022 - 11/2011
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2016
4	Interleukin-13IBA 01/2022 - 07/2006
4	GadoliniumIBA 01/2022 - 08/2012
4	Methacholine Chloride (Methacholine)FDA Link 03/2016 - 04/2011
3	HLA-A31 antigenIBA 01/2022 - 01/2017
3	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 01/2022 - 05/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2021 - 04/2002
3	CytokinesIBA 08/2021 - 01/2015
3	Lamotrigine (Lamictal)FDA LinkGeneric 01/2021 - 10/2015
3	Rituximab (Mabthera)FDA Link 01/2020 - 01/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2018 - 05/2014
2	Therapeutic UsesIBA 01/2022 - 04/2011
2	InterleukinsIBA 01/2022 - 08/2021
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2021 - 07/2006
2	Protein Glutamine gamma Glutamyltransferase 2IBA 12/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2020
2	Dapsone FDA Link 10/2020 - 01/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 03/2014
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 03/2014
2	ChlorineIBA 01/2020 - 01/2014
2	Carbonic Anhydrase InhibitorsIBA 11/2019 - 06/2010
2	Platinum Compounds (Compounds, Platinum)IBA 02/2018 - 10/2017
2	Oseltamivir (Tamiflu)FDA Link 02/2018 - 02/2012
2	Genetic Markers (Genetic Marker)IBA 01/2018 - 05/2011
2	Methazolamide FDA LinkGeneric 01/2018 - 06/2010
2	Neuromuscular Blocking AgentsIBA 10/2017 - 05/2016
2	Interleukin-23 (Interleukin 23)IBA 01/2017 - 03/2016
2	SteroidsIBA 07/2016 - 04/2011
2	indium-bleomycinIBA 03/2016 - 03/2007
2	Interleukin-17 (Interleukin 17)IBA 03/2016 - 01/2015
2	Vitamin D FDA LinkGeneric 05/2014 - 11/2013
2	HLA-B58IBA 01/2014 - 11/2011
2	Uric Acid (Urate)IBA 01/2014 - 11/2011
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2021
1	Metalloproteases (Metalloproteinases)IBA 12/2021
1	16S Ribosomal RNAIBA 10/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2021
1	cefazedoneIBA 09/2021
1	cefbuperazone (T 1982)IBA 09/2021
1	Cephalosporins (Cephalosporin Antibiotics)IBA 09/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 09/2021
1	beta-LactamsIBA 09/2021
1	Vehicle Emissions (Emissions, Vehicle)IBA 08/2021
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 08/2021
1	CalciumIBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	AcyltransferasesIBA 01/2021
1	Vancomycin FDA LinkGeneric 01/2021
1	Albendazole (Albenza)FDA Link 08/2020

Therapy/Procedure

10	Therapeutics 03/2022 - 11/2011
6	Premedication 10/2019 - 11/2011
3	Drug Therapy (Chemotherapy) 01/2019 - 01/2014
2	Intra-Arterial Injections 01/2020 - 10/2019
1	Injections 01/2021